Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Pharmacokinetics: Excretion"'
Autor:
Qianlei Wang, Ning Xiao, Zhengkun Xu, Chun Wang, Feng Xiao, Jiajie Kuai, Jinzhang Gao, Wei Wei
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 130:364-374
Paeoniflorin-6'-O-benzene sulfonate (CP-25) is a novel ester derivative of paeoniflorin, which has been shown to have synergistic pharmacodynamic effects with leflunomide (LEF). To determine the effects of CP-25 on the pharmacokinetics of LEF in rats
Publikováno v:
European Journal of Pharmaceutical Sciences. 130:11-20
The covalent binding of proteins with polyethylene glycol (PEG) molecules is a valuable tool to extend the half-life of many biotherapeutics, including factor VIII (FVIII) products to treat patients with haemophilia A. Although PEG has low toxicity,
Autor:
Teresa Fuller, Claire Ambery, Adam Hughes, Adrian Pereira, Graeme Young, Aili L. Lazaar, David Ramsay, Peter T. Daley-Yates, Frans van den Berg
Publikováno v:
Clinical Pharmacology in Drug Development
Clin Pharmacol Drug Dev
Clin Pharmacol Drug Dev
Inhaled batefenterol is an investigational bifunctional molecule for the treatment of chronic obstructive pulmonary disease. The excretion balance and pharmacokinetics of batefenterol using [14C]‐radiolabeled drug administered orally and as intrave
Publikováno v:
Food and Chemical Toxicology. 109:552-568
The pharmacokinetics, excretion balance, and tissue distribution of [14C]-labeled glycolipids from Dacryopinax spathularia (herein referred to as “AM-1”) and [14C]-LCFA equivalents following single or repeated administration to Sprague Dawley rat
Publikováno v:
Open Forum Infectious Diseases
Background Rezafungin is a once-weekly novel echinocandin antifungal currently in Phase 3 development for treatment of candidemia and invasive candidiasis (ReSTORE) and for prevention of invasive fungal disease caused by Candida, Aspergillus, and Pne
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
Zoliflodacin is a novel spiropyrimidinetrione with activity against bacterial type II topoisomerases that inhibits DNA biosynthesis and results in accumulation of double-strand cleavages in bacteria. We report results from two phase 1 studies that in
Publikováno v:
Biomedical Chromatography. 29:1581-1588
A sensitive ultrahigh performance liquid chromatography tandem mass spectrometry (UHPLC-MS) method was developed for determination of gambogic acid (GA) in rat plasma, urine, bile and main tissues. GA was separated on an Agilent Zorbax XDB–C18 colu
Publikováno v:
Molecular Medicine Reports
DL0410, a dual-action cholinesterase inhibitor and histamine-3 receptor antagonist with a novel structural scaffold, may be a potential candidate for the treatment of Alzheimer's disease (AD). To the best of the authors' knowledge, this is the first
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 132
Berberine (BBR) is a bioactive plant ingredient derived from the roots and bark of Berberis aristata and Coptis chinensis and has a wide variety of pharmacological effects. 8-cetylberberine (8-BBR-C16) is the berberine (BBR) derivative reconstructed
Autor:
Ihor Bekersky, Robert M. Fielding, Donald N. Buell, Dawna E. Dressler, Thomas J. Walsh, Sandra Kline
Publikováno v:
Journal of Clinical Pharmacology. 41:963-971
Amphotericin B (AmB) in small unilamellar liposomes (AmBisome) provides higher plasma concentrations and greater safety than the conventional deoxycholate formulation. The authors compared the disposition of the liposome's drug and cholesterol compon